Bluefin Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-13,100
Closed -$1K 818
2021
Q4
$1K Hold
13,100
﹤0.01% 889
2021
Q3
$5K Buy
+13,100
New +$2.23M ﹤0.01% 690
2019
Q4
Sell
-12,700
Closed -$38K 673
2019
Q3
$38K Buy
+12,700
New +$1.67M 0.01% 392
2018
Q4
Sell
-10,200
Closed -$26K 475
2018
Q3
$26K Buy
+10,200
New +$1.36M ﹤0.01% 427
2016
Q3
Sell
-74,700
Closed -$5K 514
2016
Q2
$5K Buy
+74,700
New +$8.49M ﹤0.01% 457
2016
Q1
Sell
-89,300
Closed -$21K 611
2015
Q4
$21K Buy
+89,300
New +$8.98M ﹤0.01% 556
2014
Q4
Sell
-48,500
Closed -$57K 806
2014
Q3
$57K Buy
+48,500
New +$5.03M ﹤0.01% 722

Other funds holding JNJ

Bluefin Capital Management's JNJ Position: Q4 2022 in Review

Bluefin Capital Management sold out of Johnson & Johnson (JNJ) in Q4 2022, closing a stake of 2,570 shares — an estimated $420K sold.

Bluefin Capital Management first reported a position in JNJ in Q2 2013 and held it in 33 quarters. The position peaked at $14.8M in Q4 2019. 3,788 funds tracked by Wall St. Rank hold JNJ as of Q4 2022.

  • Bluefin Capital Management reported no remaining Johnson & Johnson position as of Q4 2022 after selling out during the quarter.
  • Bluefin Capital Management sold 2,570 Johnson & Johnson shares in Q4 2022, an estimated $420K.
  • Bluefin Capital Management first reported a position in Johnson & Johnson in Q2 2013 and held it in 33 quarters.
  • Bluefin Capital Management's Johnson & Johnson position peaked at $14.8M in Q4 2019.
  • 3,788 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2022.

Based on Bluefin Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.